Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
How do you approach post-lumpectomy surveillance in male breast cancer patients without BRCA or other mutations?
Answer from: Radiation Oncologist at Community Practice
Annual mammograms, with additional sonogram if needed.
Sign In
or
Register
to read more
32257
Related Questions
What are your top takeaways in Radiation Oncology from SABCS 2025?
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
Would you consider RNI alone without CW for an isolated nodal recurrence after treatment with mastectomy and SNB for an early-stage breast cancer with no prior RT?
Is FAST-Forward/ultra-hypofractionation suitable for an early-stage breast patient after a lumpectomy with oncoplastic reduction?
Does pre-chemotherapy extent of nodal involvement impact your decision to offer adjuvant radiation in cN1, ypN0 triple-negative breast cancer?
How would you manage an isolated nodal recurrence of breast cancer in a patient with a prior history of mantle-field radiation?
How do you approach boost to the lumpectomy cavity AND 4 lymph nodes with extra-nodal extension when treating breast cancer with hypofractionation?
Which patient subgroups do you plan to omit regional nodal irradiation for, given the publication of NSABP B-51?
How do you optimally set a patient up for breast radiation therapy if you don't have access to a breast board or wing board?
What radiation fields would you recommend in a young patient with luminal B histology and ITCs in a single sentinel node?